Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release
Johannes Rolin, Kristin Larsen Sand, Eirunn Knudsen, et al.
Cancer Immunology Immunotherapy (2009) Vol. 59, Iss. 4, pp. 575-586
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Role of Chemokines in the Biology of Natural Killer Cells
Azzam A. Maghazachi
Current topics in microbiology and immunology (2010), pp. 37-58
Closed Access | Times Cited: 204
Inhibition of Sphingosine 1-Phosphate Lyase for the Treatment of Rheumatoid Arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)
Jeffrey T. Bagdanoff, Michael S. Donoviel, Amr Nouraldeen, et al.
Journal of Medicinal Chemistry (2010) Vol. 53, Iss. 24, pp. 8650-8662
Closed Access | Times Cited: 109
Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment
Yamila I. Rodriguez, Ludmila E. Campos, María G. Castro, et al.
Frontiers in Oncology (2016) Vol. 6
Open Access | Times Cited: 64
S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy
Narges Rostami, Afshin Nikkhoo, Amir Ajjoolabady, et al.
Molecular Diagnosis & Therapy (2019) Vol. 23, Iss. 4, pp. 467-487
Closed Access | Times Cited: 57
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
Kyu Sic You, Yong Weon Yi, Jeonghee Cho, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 589-589
Open Access | Times Cited: 48
Bioactive sphingolipids as emerging targets for signal transduction in cancer development
Wentao Jia, Jiaying Yuan, Jinbo Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189176-189176
Closed Access | Times Cited: 7
Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis
Katja Thomas, Undine Proschmann, Tjalf Ziemssen
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 15, pp. 1649-1660
Closed Access | Times Cited: 49
Drugs/agents for the treatment of ischemic stroke: Advances and perspectives
Jian Jia, Weijie Jiao, Guan Wang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 975-1012
Closed Access | Times Cited: 13
Reduction of the Peripheral Blood CD56bright NK Lymphocyte Subset in FTY720-Treated Multiple Sclerosis Patients
Trina Johnson, Barbara L. Evans, Bryce A. Durafourt, et al.
The Journal of Immunology (2011) Vol. 187, Iss. 1, pp. 570-579
Open Access | Times Cited: 58
Identification of Human NK17/NK1 Cells
Abhilash Pandya, Zaidoon Al‐Jaderi, Rune Alexander Høglund, et al.
PLoS ONE (2011) Vol. 6, Iss. 10, pp. e26780-e26780
Open Access | Times Cited: 51
Effects of Vitamin D3, Calcipotriol and FTY720 on the Expression of Surface Molecules and Cytolytic Activities of Human Natural Killer Cells and Dendritic Cells
Zaidoon Al‐Jaderi, Azzam A. Maghazachi
Toxins (2013) Vol. 5, Iss. 11, pp. 1932-1947
Open Access | Times Cited: 48
Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection
Irina V. Tiper, James E. East, Priyanka B. Subrahmanyam, et al.
Pathogens and Disease (2016) Vol. 74, Iss. 6, pp. ftw063-ftw063
Open Access | Times Cited: 42
Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis
Johannes Rolin, Azzam A. Maghazachi
Journal of Leukocyte Biology (2014) Vol. 95, Iss. 4, pp. 575-585
Closed Access | Times Cited: 38
Sphingosine-1-Phosphate Modulates Dendritic Cell Function: Focus on Non-Migratory Effects <b><i>in Vitro</i></b> and <b><i>in Vivo</i></b>
Olga Arlt, Anja Schwiebs, Lukasz Japtok, et al.
Cellular Physiology and Biochemistry (2014) Vol. 34, Iss. 1, pp. 27-44
Open Access | Times Cited: 35
<p>Gasdermin D Hypermethylation Inhibits Pyroptosis And LPS-Induced IL-1β Release From NK92 Cells</p>
Jibran Sualeh Muhammad, Manju Nidagodu Jayakumar, Noha Mousaad Elemam, et al.
ImmunoTargets and Therapy (2019) Vol. Volume 8, pp. 29-41
Open Access | Times Cited: 34
S1P Signaling in the Tumor Microenvironment
Gabriela Schneider
Advances in experimental medicine and biology (2020), pp. 129-153
Closed Access | Times Cited: 29
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor
Linda Monaco-Shawver, Lynnae Schwartz, Florin Tuluc, et al.
Journal of Leukocyte Biology (2010) Vol. 89, Iss. 1, pp. 113-125
Open Access | Times Cited: 37
Effects of Lysophospholipids on Tumor Microenvironment
Johannes Rolin, Azzam A. Maghazachi
Cancer Microenvironment (2011) Vol. 4, Iss. 3, pp. 393-403
Open Access | Times Cited: 35
Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a
Heidi Vego, Kristin Larsen Sand, Rune Alexander Høglund, et al.
Cellular and Molecular Immunology (2014) Vol. 13, Iss. 1, pp. 57-64
Open Access | Times Cited: 33
A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA)
Rune Alexander Høglund, Trygve Holmøy, Hanne F. Harbo, et al.
PLoS ONE (2013) Vol. 8, Iss. 4, pp. e62237-e62237
Open Access | Times Cited: 30
Suppression of Natural Killer Cell Cytotoxicity in Postpartum Women
Maureen Groër, Nagwa El‐Badri, Julie Y. Djeu, et al.
Biological Research For Nursing (2013) Vol. 16, Iss. 3, pp. 320-326
Open Access | Times Cited: 29
Targeting sphingosine-1-phosphate signaling for cancer therapy
Zuoquan Xie, Hong Liu, Meiyu Geng
Science China Life Sciences (2017) Vol. 60, Iss. 6, pp. 585-600
Closed Access | Times Cited: 27
<p>Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?</p>
Mena Al‐Ani, Noha Mousaad Elemam, Jennifer E. Hundt, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 3243-3254
Open Access | Times Cited: 22
Lessons from S1P receptor targeting in multiple sclerosis
Emanuela Colombo, Cinthia Farina
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107971-107971
Closed Access | Times Cited: 18
Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling
Noha Mousaad Elemam, Sarah Hammoudeh, Laila Salameh, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top